332 related articles for article (PubMed ID: 34205414)
1. Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update.
Icard P; Coquerel A; Wu Z; Gligorov J; Fuks D; Fournel L; Lincet H; Simula L
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205414
[TBL] [Abstract][Full Text] [Related]
2. ATP citrate lyase: A central metabolic enzyme in cancer.
Icard P; Wu Z; Fournel L; Coquerel A; Lincet H; Alifano M
Cancer Lett; 2020 Feb; 471():125-134. PubMed ID: 31830561
[TBL] [Abstract][Full Text] [Related]
3. The reduced concentration of citrate in cancer cells: An indicator of cancer aggressiveness and a possible therapeutic target.
Icard P; Lincet H
Drug Resist Updat; 2016 Nov; 29():47-53. PubMed ID: 27912843
[TBL] [Abstract][Full Text] [Related]
4. Understanding the central role of citrate in the metabolism of cancer cells.
Icard P; Poulain L; Lincet H
Biochim Biophys Acta; 2012 Jan; 1825(1):111-6. PubMed ID: 22101401
[TBL] [Abstract][Full Text] [Related]
5. The dual role of citrate in cancer.
Icard P; Simula L; Zahn G; Alifano M; Mycielska ME
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188987. PubMed ID: 37717858
[TBL] [Abstract][Full Text] [Related]
6. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Granchi C
Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238
[TBL] [Abstract][Full Text] [Related]
7. Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?
Icard P; Simula L; Wu Z; Berzan D; Sogni P; Dohan A; Dautry R; Coquerel A; Lincet H; Loi M; Fuks D
Drug Resist Updat; 2021 Dec; 59():100790. PubMed ID: 34924279
[TBL] [Abstract][Full Text] [Related]
8. An allosteric mechanism for potent inhibition of human ATP-citrate lyase.
Wei J; Leit S; Kuai J; Therrien E; Rafi S; Harwood HJ; DeLaBarre B; Tong L
Nature; 2019 Apr; 568(7753):566-570. PubMed ID: 30944472
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells.
Møller SH; Mellergaard M; Madsen M; Bermejo AV; Jepsen SD; Hansen MH; Høgh RI; Aldana BI; Desler C; Rasmussen LJ; Sustarsic EG; Gerhart-Hines Z; Daskalaki E; Wheelock CE; Hiron TK; Lin D; O'Callaghan CA; Wandall HH; Andresen L; Skov S
Front Immunol; 2020; 11():1968. PubMed ID: 32849657
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Citrate Is a Trojan Horse for Cancer Cells.
Petillo A; Abruzzese V; Koshal P; Ostuni A; Bisaccia F
Front Mol Biosci; 2020; 7():593866. PubMed ID: 33282912
[TBL] [Abstract][Full Text] [Related]
11. Extracellular citrate and metabolic adaptations of cancer cells.
Parkinson EK; Adamski J; Zahn G; Gaumann A; Flores-Borja F; Ziegler C; Mycielska ME
Cancer Metastasis Rev; 2021 Dec; 40(4):1073-1091. PubMed ID: 34932167
[TBL] [Abstract][Full Text] [Related]
12. A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells.
Icard P; Lincet H
Biochim Biophys Acta; 2012 Dec; 1826(2):423-33. PubMed ID: 22841746
[TBL] [Abstract][Full Text] [Related]
13. ATP citrate lyase inhibitors as novel cancer therapeutic agents.
Zu XY; Zhang QH; Liu JH; Cao RX; Zhong J; Yi GH; Quan ZH; Pizzorno G
Recent Pat Anticancer Drug Discov; 2012 May; 7(2):154-67. PubMed ID: 22339355
[TBL] [Abstract][Full Text] [Related]
14. Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway.
Ren JG; Seth P; Ye H; Guo K; Hanai JI; Husain Z; Sukhatme VP
Sci Rep; 2017 Jul; 7(1):4537. PubMed ID: 28674429
[TBL] [Abstract][Full Text] [Related]
15. Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism.
Shah S; Carriveau WJ; Li J; Campbell SL; Kopinski PK; Lim HW; Daurio N; Trefely S; Won KJ; Wallace DC; Koumenis C; Mancuso A; Wellen KE
Oncotarget; 2016 Jul; 7(28):43713-43730. PubMed ID: 27248322
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the Warburg effect: historical dogma versus current understanding.
Vaupel P; Multhoff G
J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
[TBL] [Abstract][Full Text] [Related]
17. Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect).
El Sayed SM; Mahmoud AA; El Sawy SA; Abdelaal EA; Fouad AM; Yousif RS; Hashim MS; Hemdan SB; Kadry ZM; Abdelmoaty MA; Gabr AG; Omran FM; Nabo MM; Ahmed NS
Med Hypotheses; 2013 Nov; 81(5):866-70. PubMed ID: 24071366
[TBL] [Abstract][Full Text] [Related]
18. Probing the link between citrate and malonyl-CoA in perfused rat hearts.
Poirier M; Vincent G; Reszko AE; Bouchard B; Kelleher JK; Brunengraber H; Des Rosiers C
Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1379-86. PubMed ID: 12234788
[TBL] [Abstract][Full Text] [Related]
19. Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer.
Zong H; Zhang Y; You Y; Cai T; Wang Y
Med Oncol; 2015 Mar; 32(3):85. PubMed ID: 25701462
[TBL] [Abstract][Full Text] [Related]
20. ACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate.
Keenan MM; Liu B; Tang X; Wu J; Cyr D; Stevens RD; Ilkayeva O; Huang Z; Tollini LA; Murphy SK; Lucas J; Muoio DM; Kim SY; Chi JT
PLoS Genet; 2015 Oct; 11(10):e1005599. PubMed ID: 26452058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
